Opaleye Management Inc. Ardelyx, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $2.48 Million - $3.34 Million	-471,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $2.53 Million - $3.82 Million	471,600 New	471,600 $3.26 Million
Q4 2018 Feb 14, 2019	SELL	$1.66 - $4.16 $1.08 Million - $2.7 Million	-650,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.75 - $4.65 $2.44 Million - $3.02 Million	650,000 New	650,000 $2.83 Million
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.8 $4.2 Million - $6.59 Million	-1,135,600 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$5.05 - $7.9 $1.19 Million - $1.86 Million	235,600 Added 26.18%	1,135,600 $5.73 Million
Q4 2017 Feb 09, 2018	BUY	$4.85 - $7.8 $969,999 - $1.56 Million	200,000 Added 28.57%	900,000 $5.94 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $3.04 Million - $3.99 Million	700,000	700,000 $3.92 Million

207

143M

1.01M

1.43M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $928M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.